Chromadex Corp (NAGE): Rasio kapitalisasi pasar marang pendapatan

Despite the risks of global raw material supply chain disruptions, ChromaDex Corp (NAGE) management is focusing on patents in the field of cellular longevity. The P/S ratio trend clearly demonstrates the balance between market value and actual sales, where 1.40 serves as the current metric level. The brand's high authority in the anti-aging components segment promises stable growth in share prices in the future.

Rasio rega marang pendapatan: ChromaDex Corp. (NAGE) kanggo 20.03.2025 - 13.11.2026

Rincian metrik lan analitis perusahaan Niagen (NAGE)

- kuotasi lan prakiraan analis:

Rega ChromaDex Corp.|NAGE - Bagan rega target

- data kapitalisasi bursa:

Nilai pasar Niagen|NAGE - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator kapitalisasi buku:

Nilai Buku saben Saham ChromaDex|NAGE - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih niagenbioscience.com|NAGE - Total Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- indikator profitabilitas perusahaan lan kelipatan valuasi:

NAGE - Bathi resik|Penghasilan resik sing dikarepake Chromadex Corp|NAGE - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi ChromaDex|NAGE - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Niagen|NAGE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan ChromaDex|NAGE - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan niagenbioscience.com|NAGE - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Chromadex Corp

- data total pendapatan lan volume dodolan:

NAGE - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Niagen|NAGE - Kapitalisasi marang pendapatan|Kapitalisasi marang prakiraan pendapatan Niagen

Ringkesan analitik perusahaan:niagenbioscience.com

Chromadex Corp. supplement sales are subject to moderate cyclicality and are sensitive to consumer wellness spending. Analyzing the historical P/S chart, an investor can observe the ratio of market capitalization to annual revenue, which allows for an assessment of the value of each dollar of sales and determines whether the asset's current price is justified by the business's actual cash flows.

Pesaing Chromadex Corp

Kapitalisasi marang volume dodolan ISRG|Rasio rega marang pendapatan Danaher DHR|Rasio kapitalisasi pasar marang pendapatan BDX|STE: Kapitalisasi marang pendapatan|WST - Multiplikator P/S|Baxter International (BAX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan masimo.com|STVN (Stevanato Group) - Multiplikator P/S|Rega marang dodolan Teleflex Inc. TFX|Rasio rega marang pendapatan Merit Medical Systems Inc (MMSI)|Nobel Biocare - Rasio kapitalisasi marang pendapatan|ICU Medical, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan XRAY (dentsplysirona.com)|LMAT - Rasio rega marang pendapatan|Koefisien rega marang pendapatan AtriCure Inc ATRC|STAA: Multiplikator P/S|Kapitalisasi marang pendapatan ZimVie Corp|ANGO (AngioDynamics, Inc.) - Multiplikator P/S|CERS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Teknova (TKNO)|MGRM (Monogram Technologies Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Sharps Technology STSS|InfuSystem (INFU) - Rega marang dodolan|UTMD - Rasio rega marang pendapatan|KORU Medical Systems (KRMD) - Kapitalisasi marang pendapatan|NYXH: Multiplikator P/S|Microbot Medical, Inc. (MBOT) - Multiplikator P/S|PDEX (Pro-Dex Corp) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ZTEK (Zentek Corp)|Multiplikator P/S ELUT|MLSS - Rega marang dodolan|NEXGEL - Kapitalisasi marang pendapatan|RVP: Rasio kapitalisasi marang pendapatan|HBIO: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan FEMY (Femasys Corporation)|MHUA: Multiplikator P/S|Kapitalisasi marang pendapatan Predictive Oncology Inc.|Rasio rega marang pendapatan Callan JMB Inc.|Rega marang dodolan Atrion Corp. ATRI|Rasio rega marang pendapatan NeuroMetrix Corp (NURO)